Table 2 Overall survival analysis in AIS patients and subgroups
From: Detection of E2A-PBX1 fusion transcripts in human non-small-cell lung cancer
Group | Gender | E2A-PBX1 status | Patient number | Median survival (months) | 95% CI | P value |
|---|---|---|---|---|---|---|
AIS patients | Female | 53 | 105.60 | 63.95 ~ 147.25 | 0.0378 | |
Male | 23 | 56.20 | 22.34 ~ 90.06 | |||
AIS patients with E2A-PBX1 | Female | 12 | 56.20 | 37.46 ~ 74.94 | 0.6401 | |
Male | 5 | 56.20 | 0.00 ~ 122.80 | |||
AIS patients without E2A-PBX1 | Female | 41 | 105.60 | 63.45 ~ 147.75 | 0.0345 | |
Male | 18 | NR | NA | |||
AIS patients | + | 17 | 56.20 | 44.37 ~ 68.03 | 0.1235 | |
- | 59 | 105.60 | 63.95 ~ 147.25 | |||
AIS stage I patients | + | 10 | 56.20 | 38.38 ~ 74.02 | 0.1753 | |
- | 41 | 105.60 | 63.65 ~ 147.55 | |||
AIS female patients | + | 12 | 56.20 | 37.46 ~ 74.94 | 0.0747 | |
- | 41 | 105.60 | 63.45 ~ 147.75 | |||
AIS stage IA patients | + | 6 | NR | NA | 0.0363 | |
- | 18 | NR | NA | |||
AIS stage IA female patients | + | 4 | 46.70 | 8.77 ~ 84.63 | 0.0174 | |
- | 13 | 105.60 | NA |